Skilled professional with nine (9) years of experience in the pharmaceutical industry, providing leadership in manufacturing and quality management. Expertise in particulate mitigation fostering improved product quality, reduced product rejects, and support of R&D projects: sub-visible testing (light obscuration and microscopy), investigational work studying intrinsic and extrinsic particulate matter, container/closer, and particulate reject characterization as per USP <788> and <790>. Solid pharmaceutical background, including expertise in cGMP CFR 21, GLP, Method Validation, ICH Q2, and SUPAC.
Chemistry Research Advisor: Distinguished Professor Iwao Ojima
Research Project Assistant: August 2007 to January 2013
Dissertation: "Drug Discovery Through Combination of Computational Screening and Design, Chemical Synthesis and Biological Evaluations" 2013
Chemistry and History
Biology-transfer Resident Computer Assistant 1999 - 2001 Champlain Hall.
1. Kumar, K.; Awasthi, D.; Berger, W. T.; Tonge, P. J.; Slayden, R. A.; Ojima, I. Discovery of anti-TB agents that target the cell-division protein FtsZ., Future Medicinal Chemistry, 2010, 2, 1305- 1323
2. Ojima, I.; Zuniga, E. S.; Berger, W. T.; Seitz, J. D., Tumor-targeting drug delivery of new-generation taxoids., Future Medicinal Chemistry, 2012, 4, 33 50
3. Berger W. T.; Ralph B. P.; Kaczocha M.; Sun J.; Balius T. E.; Rizzo, R. C.; Haj-Dahmane, S.; Ojima, I.; Deutsch, D. G. Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs., PLoS ONE, 2012, 7(12): e50968
4. Kaczocha, M.; Rebecchi, M. J.; Ralph, B. P.; Teng, G. Y-H.; Berger, W. T.; Galbavy, W.; Elmes, M. W.; Glaser, S. T.; Wang, L.; Rizzo, R. C.; Deutsch, D. G.; Ojima, I. Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia., PLoS ONE, 2014, 9(4): e942005. Ojima, I.; Deutsch, D.; Kaczocha, M.; Berger, W. T.; Rizzo, R.; Balius, T. E., 2013. - and - truxillic acid derivatives and pharmaceutical compositions thereof. US2013051337, WO2014015276, filed July 19th, 2013, and issued January 23rd, 2014.
Resumes, and other information uploaded or provided by the user, are considered User Content governed by our Terms & Conditions. As such, it is not owned by us, and it is the user who retains ownership over such content.
Many factors go into creating a strong resume. Here are a few tweaks that could improve the score of this resume:
Job Titles Held: